How far off is Omega Flex, Inc. (NASDAQ:OFLX) from its intrinsic value? Using the most recent financial data, we'll take a look at whether the stock is fairly priced by taking the ...
Using the 2 Stage Free Cash Flow to Equity, Monopar Therapeutics fair value estimate is US$168 Monopar Therapeutics is estimated to be 46% undervalued based on current share price of US$91.56 The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback